secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0000950170-25-114089
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical announces 1-for-15 reverse stock split, authorized shares reduced to 26.7M
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-15 ratio; effective 5:00 p.m. ET on Sept 12, 2025.
- Authorized shares reduced from 400M to 26,666,666; no change to par value.
- Trading on split-adjusted basis on Nasdaq Capital Market starting Sept 15, 2025; new CUSIP 185063203.
- No fractional shares; cash paid in lieu; proportionate adjustments to stock options, RSUs, warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017025114089/0000950170-25-114089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017025114089/clsd-20250910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-114089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer